Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5AP | P20292 | 1/20 | 0.42 |
| ▸ | PIM1 | P11309 | 8/20 | 0.42 |
| ▸ | PIM3 | Q86V86 | 7/20 | 0.42 |
| ▸ | PIM2 | Q9P1W9 | 7/20 | 0.42 |
| ▸ | HCRTR1 | O43613 | 6/20 | 0.41 |
| ▸ | HCRTR2 | O43614 | 6/20 | 0.41 |
| ▸ | LRRK2 | Q5S007 | 1/20 | 0.41 |
| ▸ | GRM5 | P41594 | 2/20 | 0.40 |
| ▸ | MET | P08581 | 2/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15338817 | 0.79 | NAMPT (0.52) | HCRTR1HCRTR2GRM5 | |
| SCHEMBL9977750 | 0.79 | FEN1 (0.50) | HCRTR1HCRTR2GRM5 | |
| Hydrochloric Acid SCHEMBL15327063 | 0.78 | FEN1 (0.49) | HCRTR1HCRTR2GRM5 | |
| SCHEMBL15604646 | 0.75 | HCRTR1 (0.52) | HCRTR1HCRTR2GRM5 | |
| Hydrochloric Acid SCHEMBL16648614 | 0.74 | HCRTR1 (0.51) | HCRTR1HCRTR2GRM5 | |
| SCHEMBL9977865 | 0.74 | HCRTR1 (0.53) | HCRTR1HCRTR2GRM5 | |
| SCHEMBL15327052 | 0.74 | HCRTR1 (0.42) | HCRTR1HCRTR2GRM5 | |
| SCHEMBL25323896 | 0.72 | CSNK1D (0.35) | LRRK2GRM5 | |
| SCHEMBL16648654 | 0.72 | HCRTR1 (0.46) | HCRTR1HCRTR2GRM5 | |
| SCHEMBL16561338 | 0.72 | MKNK1 (0.50) | ALOX5APPIM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023177233-A1 | NOVEL COMPOUND AND USE THEREOF FOR INHIBITING CHECKPOINT KINASE 2 | (주)아름테라퓨틱스 | 2023-09-21 | — | — | WO | disclosed |